Treatment of erythematous acne scars using 595‐nm pulsed dye laser combined with 1565‐nm ResurFX nonablative fractional laser
Journal of Cosmetic Dermatology · 2024-06 · 23 (6) · 2015-2021
DOI: 10.1111/jocd.16235 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2024-03. Verfasst von Chenxi Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: DEXI Clinc, DE YI Skin, Xi'An, Shanxi, China. Hauptthemen laut MEDLINE: Lasers, Dye, Acne Vulgaris, Cicatrix, Erythema. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acne vulgaris is a common inflammatory disease associated with various sequelae after skin lesion remission. Acne erythema has been considered simple erythema or a vascular lesion; however, because the understanding of this disease has improved, acne erythema is currently considered an early scar with erythematous components.
Aims
This study evaluated the efficacy of using both a 595‐nm pulsed dye laser (PDL) and 1565‐nm nonablative fractional laser (NAFL) for the treatment of erythematous scars caused by acne.
Methods
Ninety patients with acne scars were equally randomized to two groups. Group A ( n = 45) received treatment with the NAFL. Group B ( n = 45) received treatment with the PDL and NAFL. Each patient underwent one treatment session and 4 weeks of follow‐up.
Results
Qualitative (χ 2 = 12.415; p < 0.05) and quantitative ( t = 2.675; p < 0.05) scores of Groups A and B were determined using a global scarring grading system and exhibited statistically significant differences. The quantitative score of Group A was higher than that of Group B (6.67 ± 3.46 vs. 4.98 ± 2.44). The erythema areas of the groups differed significantly after treatment, with Group B exhibiting more notable score improvements (5.00 [3.10, 7.10] vs. 2.80 [1.65, 4.60]; Z = 3.072; p < 0.05). The erythema regression rate of Group B (88.9%) was significantly higher than that of Group A (66.7%) ( χ 2 = 20.295; p < 0.001). Adverse events, including redness and swelling (86.6%), scabbing (78.8%), and purpura (36.6%), occurred within 7 days for 86.6% of patients.
Conclusions
The combined use of the PDL and NAFL is safe and effective for erythematous acne scars.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- DEXI Clinc, DE YI Skin, Xi'An, Shanxi, China.
- DEYUE Clinc, DE YI Skin, Shenzhen, China.
- Peking University Shenzhen Hospital, Shenzhen, China.
Zitieren
APA
Zhou, C., Yao, M., Chen, W., Zhang, L., Zhang, L., Chen, M., Li, K., & Qin, X. (2024). Treatment of erythematous acne scars using 595‐nm pulsed dye laser combined with 1565‐nm ResurFX nonablative fractional laser. Journal of Cosmetic Dermatology, 23(6), 2015-2021. https://doi.org/10.1111/jocd.16235
Vancouver
Zhou C, Yao M, Chen W, Zhang L, Zhang L, Chen M, et al. Treatment of erythematous acne scars using 595‐nm pulsed dye laser combined with 1565‐nm ResurFX nonablative fractional laser. Journal of Cosmetic Dermatology. 2024;23(6):2015-2021. doi:10.1111/jocd.16235
BibTeX
@article{Zhou2024,
author = {Zhou, Chenxi and Yao, Meijuan and Chen, Weiliang and Zhang, Liyuan and Zhang, Lidan and Chen, Mengjiao and Li, Kai and Qin, Xiaolei},
title = {Treatment of erythematous acne scars using 595‐nm pulsed dye laser combined with 1565‐nm ResurFX nonablative fractional laser},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
volume = {23},
number = {6},
pages = {2015--2021},
doi = {10.1111/jocd.16235}
}
EUVIMED